Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome is a common hormonal disorder in women that affects health and fertility.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

The study found that 7.21% of young girls have polycystic ovarian syndrome, with symptoms like irregular periods, abnormal hair growth, and acne. Early diagnosis is important to prevent long-term complications.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

Urinary stone cases in Wuwei City increased significantly from 1995 to 2016.

Organizations help patients access discounts for expensive dermatology medications.

Surgical removal of a rare ovarian tumor improved symptoms and hormone levels in a postmenopausal woman.

Drug repositioning offers a cost-effective, lower-risk way to treat diseases and pandemics like COVID-19.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

A woman had a skin reaction from a cough suppressant, dextromethorphan, which is a new cause of fixed-drug eruption.

Early diagnosis and lifestyle changes are crucial for managing PCOD.

High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

Medroxyprogesterone acetate is as effective as oral contraceptives for resuming ovulation in women with PCOS.

COVID-19 significantly affected healthcare professionals.

The article concludes that better diagnosis and management of Polycystic Ovarian Syndrome are needed to improve women's health and prevent related diseases.

During the COVID-19 lockdown, there were fewer cases of mild skin issues and more cases of stress-related skin conditions.

The COVID-19 pandemic has led to more severe cases of Leprosy due to delayed medical care.

Advocacy groups should avoid marketing partnerships that may imply drug endorsements.

Polycystic Ovary Syndrome (PCOS) is a complex disorder with both immediate and long-term health effects, including menstrual issues, infertility, and increased risk of diabetes and heart disease.

PCOS is common, affects hormones, and often diagnosed late, impacting women's quality of life.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Doctors should recognize and treat PCOS early in primary care to manage symptoms and lower risk of other health issues.

Continued vaccine and drug development is crucial due to new virus variants and regional infection spikes.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.